Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Stevanato Group SpASTVN -0.93%86 Equity-to-Asset is 0.59 as of Jun. 2026, which is at its 10-year median of 0.59. GuruFocus rates STVN with a GF Score™ of 86/100 and a GF Value™ of $26.04 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 851 Medical Devices & Instruments companies, Stevanato Group SpA ranks worse than 55.58% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Stevanato Group SpA's Total Stockholders Equity for the quarter that ended in Jun. 2026 was $1,785 Mil. Stevanato Group SpA's Total Assets for the quarter that ended in Jun. 2026 was $3,017 Mil.
Therefore, Stevanato Group SpA's Equity to Asset Ratio for the quarter that ended in Jun. 2026 was 0.59.
The historical rank and industry rank for Stevanato Group SpA's Equity-to-Asset or its related term are showing as below:
STVN'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.3 Med: 0.59 Max: 0.61
Current: 0.59
During the past 8 years, the highest Equity to Asset Ratio of Stevanato Group SpA was 0.61. The lowest was 0.30. And the median was 0.59.
STVN's Equity-to-Asset is ranked worse than 55.58% of 851
companies
in the Medical Devices & Instruments industry
Industry Median: 0.64
vs STVN: 0.59
Stevanato Group SpA (NYSE:STVN) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Stevanato Group SpA Equity-to-Asset Related Terms
Stevanato Group SpA Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Stevanato Group SpA's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STVN vs MMED, TFX, MMSI: Equity-to-Asset Comparison
For the Medical Instruments & Supplies subindustry, Stevanato Group SpA's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Stevanato Group SpA Equity-to-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Stevanato Group SpA's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Stevanato Group SpA's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Stevanato Group SpA's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Stevanato Group SpA (STVN) has a Equity-to-Asset of 0.59 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Stevanato Group SpA and its competitors. This is near median its historical median of 0.59. Over the past decade, Stevanato Group SpA's Equity-to-Asset has ranged from 0.30 to 0.61. According to the industry distribution chart, Stevanato Group SpA ranks #473 out of 851 companies in the Medical Devices & Instruments industry, placing it in the top 55.6%.
Is Stevanato Group SpA's Equity-to-Asset too high?
Stevanato Group SpA's current Equity-to-Asset of 0.59 is near median its 10-year median of 0.59. Over the past 10 years, this metric has ranged from a low of 0.30 to a high of 0.61. The Medical Devices & Instruments industry median Equity-to-Asset is 0.64. Stevanato Group SpA's value of 0.59 is 7.8% below this industry median. Based on the distribution chart, Stevanato Group SpA ranks #473 out of 851 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Stevanato Group SpA has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Stevanato Group SpA's Equity-to-Asset compare to MMED and TFX?
According to the Medical Devices & Instruments industry distribution chart, Stevanato Group SpA ranks #473 out of 851 companies for Equity-to-Asset. This places Stevanato Group SpA in the lower half of its industry. The industry median Equity-to-Asset is 0.64. Stevanato Group SpA's value of 0.59 is 7.8% below this benchmark. Historically, Stevanato Group SpA's own Equity-to-Asset has ranged from 0.30 to 0.61 over the past decade. While the company's 10-year median is 0.59 vs. the industry median of 0.64, Stevanato Group SpA has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Devices & Instruments company?
The median Equity-to-Asset among Medical Devices & Instruments companies is 0.64, based on 851 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Stevanato Group SpA's current Equity-to-Asset of 0.59 is 7.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Stevanato Group SpA and its competitors. For the Medical Devices & Instruments industry, the median Equity-to-Asset is 0.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Stevanato Group SpA's current Equity-to-Asset is 0.59, which is near median its own 10-year median of 0.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stevanato Group SpA stock overvalued right now?
Based on GuruFocus' analysis, Stevanato Group SpA (STVN) is currently considered Modestly Undervalued. The stock's GF Value™ is $26.04, compared to a current price of $20.32 — trading 22% below its estimated fair value. The current Equity-to-Asset is 0.59, which is near median its 10-year median of 0.59 and 7.8% below the Medical Devices & Instruments industry median of 0.64. Stevanato Group SpA's overall GF Score™ is 86/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Stevanato Group SpA (STVN), the current Equity-to-Asset is 0.59 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Stevanato Group SpA (STVN) Overvalued in 2026?
Based on GuruFocus' analysis, Stevanato Group SpA stock appears to be undervalued.
The current stock price of $20.32 is trading 22% below its estimated GF Value™ of $26.04.
GuruFocus considers Stevanato Group SpA to be Modestly Undervalued.
Key valuation signals for STVN:
Equity-to-Asset: 0.59 (near median its 10-year median of 0.59)
GF Value™: $26.04 vs. price of $20.32 (22% below fair value)
Industry Position: 7.8% below the Medical Devices & Instruments median (#473 of 851)
No single metric tells the full story. See the STVN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.
86GF Score
Get the complete analysis for STVN
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STVN has been successfully added to your 
